Skip to main content
Banner for bioMérieux's Critical Conversations: Voices of AMR Experts podcast series, featuring illustrated healthcare professionals, a microphone and an audio waveform.

Explore Our Podcast Series

Critical Conversations: Voices of AMR Experts

Expert conversations on antimicrobial resistance (AMR), antimicrobial stewardship (AMS), diagnostic stewardship and the role of rapid diagnostics in healthcare settings around the world.

Explore the Series

Antimicrobial resistance (AMR) is a major global healthcare challenge. Critical Conversations: Voices of AMR Experts is a podcast series featuring healthcare professionals sharing their experiences and perspectives on antimicrobial resistance, antimicrobial stewardship (AMS), diagnostic stewardship and clinical decision-making.

Through discussions from different healthcare settings around the world, explore topics including antimicrobial resistance surveillance, stewardship program implementation, rapid diagnostic testing, point-of-care testing (POCT), syndromic testing and the role of diagnostics in patient management.

The latest episode

bioMérieux Critical Conversations podcast episode 10 artwork on the clinical value of diagnostic testing and the STRIDE framework, featuring Dr. Luke Moore and Prof. Maria Virginia Villegas.

Episode 10: From results to action making every test count

In this episode, Dr. Luke Moore and Prof. Maria Virginia Villegas discuss how the STRIDE framework helps quantify the clinical value of diagnostics. They explore the dilemma of broad-spectrum versus narrow-spectrum antibiotic therapy, explain why mortality may not be the most relevant endpoint for evaluating rapid diagnostics, and discuss how timely diagnostic results can support antimicrobial stewardship, infection control, and antimicrobial resistance (AMR) surveillance.


Other episodes

bioMérieux Critical Conversations podcast episode 9 artwork on antimicrobial stewardship (AMS) and the DRIVE-AMS program, featuring Dr. Jeroen Schouten and Dr. Francisco Almeida.

Episode 9: ESCMID Global Special - Driving change in antimicrobial stewardship with DRIVE-AMS

In this episode recorded at ESCMID Global 2026 in Munich, we welcome Dr. Jeroen Schouten and Dr. Francisco Almeida to explore how the DRIVE-AMS program is transforming antimicrobial stewardship through behavioural change. Together, they discuss how data-driven interventions, tailored feedback, and multidisciplinary collaboration can sustainably improve antimicrobial prescribing practices across hospitals.

bioMérieux Critical Conversations podcast episode 8 artwork on rapid PCR testing for pneumonia in intensive care units (ICU), featuring Dr. Wadha Al Fuzan and Dr. Abdel Rahman Al Fares.

Episode 8: Fast multiplex PCR testing for pneumonia in intensive care units

In this episode, we talk with two experts from Kuwait: Dr. Wadha Al Fuzan, clinical microbiologist and Dr. Abdel Rahman Al Fares, consultant intensivist, about pneumonia management in intensive care units (ICU). They discuss how rapid diagnostics, particularly multiplex PCR testing, are transforming pneumonia management by enabling faster, more targeted treatment, supporting antimicrobial stewardship, and improving patient outcomes.

bioMérieux Critical Conversations podcast episode 7 artwork on point-of-care (POC) testing in children, featuring Dr. Zainab Malik and Dr. David Aman Eddine.

Episode 7: Impact of point-of-care testing in children

In this episode, we talk with Dr. Zainab Malik and Dr David Aman Eddine, two pediatric experts from Dubai about the role and impact of point-of-care testing (POCT) in children. They discuss how rapid point-of-care diagnostics support better clinical decisions, help avoid unnecessary hospitalizations, and reduce costs through more efficient patient management.

bioMérieux Critical Conversations podcast episode 6 artwork on syndromic testing and clinical outcomes, featuring Dr. Shradha Subedi and Dr. Umang Agrawal.

Episode 6: Impact of syndromic testing on patient clinical outcome

In this special ESCMID episode, Dr. Shradha Subedi and Dr. Umang Agrawal introduce their latest studies on the impact of rapid syndromic testing, one conducted in Australia and the other in India. Together, they discuss how these diagnostics influence clinical decisions, the differences in patient management across regions, and the broader implications for the antimicrobial landscape.

bioMérieux Critical Conversations podcast episode 5 artwork on monitoring antimicrobial resistance (AMR) with the Global Point Prevalence Survey (Global-PPS), featuring Erika Vlieghe and Ann Versporten.

Episode 5: ESCMID Global Special - Monitoring antimicrobial resistance with the Global-PPS

In this special episode, recorded at ESCMID Global 2025 in Vienna, we welcome two antimicrobial resistance (AMR) experts, Erika Vlieghe and Ann Versporten. They explore the impact of the Global Point Prevalence Survey (Global-PPS) program and highlight its major role in monitoring antimicrobial use and resistance, sharing insights from its global implementation.

bioMérieux Critical Conversations podcast episode 4 artwork on antimicrobial resistance (AMR) data and treatment guidelines, featuring Dr. Marybeth Maritim and Dr. Kenneth Iregbu.

Episode 4: From AMR data to local treatment guidelines

In this episode, we explore antimicrobial resistance (AMR) in Nigeria and Kenya. Our two hosts, Dr Marybeth Maritim and Dr. Kenneth Iregbu, highlight the importance of local guidelines in guiding therapy, as empiric treatment remains common. Reliable diagnostic tests and effective antimicrobial resistance data analysis are crucial for developing these local treatment guidelines.

Podcast image

Episode 3: The crucial role of diagnostic stewardship in AMR control

In this last episode in Egypt, Dr. Sherine Shawky and Dr. Lobna Shalaby discuss the crucial role of diagnostics and diagnostic stewardship in antimicrobial resistance (AMR) control. They share success stories, practical strategies, and valuable advice for improving diagnostic stewardship in clinical laboratories.

bioMérieux Critical Conversations podcast episode 2 artwork on antimicrobial stewardship (AMS) program implementation, featuring Dr. Lobna Shalaby and Dr. Ahmed Mokhtar.

Episode 2: Implementation of antimicrobial stewardship programs

In this episode, we welcome Dr. Lobna Shalaby and Dr. Ahmed Mokhtar to explore the challenges and successes of implementing antimicrobial stewardship (AMS) programs in their healthcare settings. They share practical insights and personal experiences to provide valuable guidance for similar antimicrobial stewardship initiatives.

bioMérieux Critical Conversations podcast episode 1 artwork on antimicrobial resistance (AMR) in Egypt, featuring Dr. Sherine Shawky and Dr. Mostafa Alfishawy.

Episode 1: The context of antimicrobial resistance in Egypt

Let’s start this podcast series with two experts who dive into the reality of antimicrobial resistance (AMR) in Egypt. Dr. Sherine Shawky, a laboratory microbiologist, and Dr. Mostafa Alfishawy, an infectious disease physician, discuss the Egyptian healthcare system and the challenges they face in tackling antimicrobial resistance, a silent pandemic.


Listen Anywhere

Critical conversations: Voices of AMR experts is available on most podcast platforms.

The scientific content in the above materials has been developed independently by the speaker(s)/author(s). The views presented in these materials are the authors’ personal opinions and do not necessarily represent the viewpoint, strategy or opinions of bioMérieux.

The content on this website and associated materials may discuss scientific research, emerging evidence, or clinical practices that may not be approved, cleared, or available in all countries. Such information is provided solely for educational and scientific exchange and users are responsible for consulting and complying with applicable local law and regulatory requirements. The content on this website and associated materials do not constitute medical advice and should not be considered a substitute for the individual professional judgement of any physician or other health care practitioner regarding the appropriate course of action for a particular patient. All recommendations should be independently reviewed with appropriate medical staff in light of the needs of any particular institution and its patients. bioMérieux makes no guarantee or representation regarding the accuracy, completeness, or usefulness of this information for any particular purpose, including but not limited to any cost savings.